Results 291 to 300 of about 352,762 (346)

Shared Decision-Making in Treatment Selection in Multiple Myeloma in Spain: The PRISMMA Study. [PDF]

open access: yesEur J Haematol
Cabañas V   +5 more
europepmc   +1 more source

USP10 in Neurological Disorders: Mechanistic Insights and Emerging Therapeutic Strategies

open access: yesAnnals of the New York Academy of Sciences, EarlyView.
USP10 is a deubiquitinating enzyme that affects neurological diseases through multiple mechanisms, including the accumulation of toxic proteins, autophagy, and immune responses. In this review, we discuss the structure and characteristics of USP10 and summarize the role of USP10 in neurological disorders.
Celemuge   +5 more
wiley   +1 more source

Sarcopenia in Older Patients with Newly Diagnosed Multiple Myeloma.

open access: yesGerontology
Sobrini-Morillo P   +9 more
europepmc   +1 more source

Identification and transformation of novel targets for immunotherapy in multiple myeloma. [PDF]

open access: yesChin Med J (Engl)
Wang Y   +6 more
europepmc   +1 more source

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia

open access: diamond
M. V. Solovev   +35 more
openalex   +2 more sources

Unmasking Oligosecretory multiple myeloma: a case report highlighting diagnostic pitfalls. [PDF]

open access: yesOxf Med Case Reports
Solórzano Flores C   +3 more
europepmc   +1 more source

Prognostic and therapeutic implications of disulfidptosis-related genes in multiple myeloma. [PDF]

open access: yesFront Immunol
Zang Y   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy